CAS 69467-96-5

Phthalazine, 1,4-dihydrazinyl-, methanesulfonate (1:1)

Description:

Phthalazine, 1,4-dihydrazinyl-, methanesulfonate (1:1) is a chemical compound characterized by its unique structure, which includes a phthalazine core substituted with two hydrazine groups and a methanesulfonate moiety. This compound typically appears as a crystalline solid and is soluble in polar solvents due to the presence of the methanesulfonate group, which enhances its hydrophilicity. It is often studied for its potential biological activities, including its role in medicinal chemistry, where it may exhibit antitumor or antimicrobial properties. The presence of the hydrazine functional groups can also contribute to its reactivity, making it a candidate for various chemical transformations. Safety data indicates that, like many hydrazine derivatives, it should be handled with care due to potential toxicity and reactivity. Overall, this compound represents an interesting subject for research in both synthetic and medicinal chemistry, with implications for drug development and chemical synthesis.

Formula: C₈H₁₀N₆·CH₄O₃S

InChI: InChI=1S/C8H10N6.CH4O3S/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7;1-5(2,3)4/h1-4H,9-10H2,(H,11,13)(H,12,14);1H3,(H,2,3,4)

InChI key: InChIKey=DRFCWYSGNDFNPW-UHFFFAOYSA-N

SMILES: N(N)=C1C=2C(C(=NN)NN1)=CC=CC2.S(C)(=O)(=O)O

Synonyms:

• Phthalazine, 1,4-dihydrazinyl-, methanesulfonate (1:1)
• 1,4-Phthalazinedione, 2,3-dihydro-, dihydrazone, monomethanesulfonate
• 2,3-Dihydrophthalazine-1,4-dione dihydrazone monomethanesulphonate

Dihydralazine mesylate

CAS: 69467-96-5

Dihydralazine mesylate is a hypotensive agent that lowers blood pressure by dilating the peripheral arterioles. It has a hydrophobic structure and is metabolized by reaction with metoprolol to form dihydralazine lactam, which is also a potent vasodilator. Dihydralazine mesylate has been shown in animals to lower systolic and diastolic blood pressure. This drug can also be used as an adjuvant therapy for primary pulmonary hypertension, where it reduces pulmonary vascular resistance and improves perfusion of the lungs. Dihydralazine mesylate does not cause any significant adverse reactions or interactions with other drugs when administered orally.

Formula: C₉H₁₄N₆O₃S

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 286.31 g/mol

Ref: 3D-FD57977